Global Remote Patient Monitoring (RPM) Market - 2020-2027
|遠端患者監護 (RPM)的全球市場:2020年∼2027年 Global Remote Patient Monitoring (RPM) Market - 2020-2027|
|出版日期: 2020年12月04日||內容資訊: 英文||
全球遠端患者監護 (RPM) 市場成長，由於老年人口增加和擴大獲得醫療保健的需求高漲，慢性疾病的發生率增加，減輕醫療資源負擔的RPM的優點，遠程醫療和遠端患者監護的成本效益，通訊的進步，對遠程醫療與RPM的增資等而受到促進。
本報告提供全球遠端患者監護 (RPM) 市場相關調查分析，產業分析，各市場區隔的市場分析，競爭情形，主要企業等相關的系統性資訊。
The global remote patient monitoring (RPM) market size was worth US$ XX billion in 2018 and is estimated to reach US$ XX billion by 2027, growing at a CAGR of XX % during the forecast period (2020-2027).
Remote patient monitoring is a method of healthcare delivery that uses the advancements in information technology to gather the patient data outside of traditional healthcare settings. There are several benefits of remote patient monitoring (RPM) for clinicians such as ease of access to patient data, the ability to deliver higher-quality care to more patients with a lower risk of burnout; and for healthcare providers such as lower costs and higher efficiency. RPM improves patient behavior by creating a system by which people are more engaged with and accountable for their health. It is difficult for some patients to access caregivers in some regions; hence, remote patient monitoring increases the capacity for physicians to treat more patients.
The global remote patient monitoring (RPM) market growth is driven by several factors such as rising geriatric population and the growing need to expand healthcare access, growing incidences of chronic diseases, benefits of RPM to reduce the burden on medical resources, cost benefits of telehealth and remote patient monitoring, advancements in telecommunications, and increasing investments in telehealth and RPM.
The growth of the geriatric population is driving the demand for healthcare and long-term care services and has increased the burden on governments and health systems. As per the World Health Organization (WHO) data, the percentage of geriatric population is expected to reach 16.0% in 2050. Ageing is one of the greatest risk factors for chronic conditions. The rising geriatric population and high susceptibility towards chronic conditions such as cardiovascular disorder, diabetes, and sleep disorder are expected to positively influence the product demand in the forecast period. This will drive the market for remote patient monitoring. Remote patient monitoring enhances the overall reach of and access healthcare while reducing unnecessary visits, hospital admissions & readmissions, and the time and costs involved in travelling to meet healthcare professionals.
Increasing support in form government programs and innovation are projected to drive the RPM market growth. For instance, the Centre for Technology and Aging based in California is devoted to rapid technological advancements in a remote patient monitoring system which leads to maintenance of independent and healthier living. The demand for this equipment in post-acute care has increased the role of the patients in self-health management. This ability to augment self-management skills with advanced tools is expected to be a high impact on market growth.
One of the factors hindering the market growth of RPM is healthcare fraud. It is an important consideration in the area of telehealth and telemedicine practices. There are several ways a patient or a physician can be victimized of healthcare fraud. For instance, the physician's details such as name and accounts can be used to receive payments from the insurance company, or non-listed institutional providers can practice improper coding and billing for false claims.
The COVID-19 is affecting the global economy by directly affecting production and demand, by disturbing the supply chain and market disruption, and by its financial impact on firms and financial markets.
However, the COVID-19 pandemic is providing immense opportunities for remote patient monitoring solutions, considering that social distancing is the only existing solution developed so far, which is capable of minimizing exposure. In line with this, remote patient monitoring represents an attractive, effective, and affordable option. In addition, this technology is of critical importance in keeping healthcare providers safe. The emergency need for social distancing among clinicians and patients has catalyzed the demand for telemedicine services. This is expected to drive the Remote Patient Monitoring (RPM) market during the forecast period.
The global remote patient monitoring (RPM) market is segmneted into product type, application, and end-user.
By Devices, Special monitors Dominate the Global Remote Patient Monitoring (RPM) Market.
By product type, the RPM market is segmented into services& software and devices. In the devices, the special monitors segment help the largest market share in 2019, owing to its ability to monitor clinical data pre and post-surgery, to identify symptoms and to prevent complications. In addition, advanced features such as wireless communication and iPad connectivity allow early diagnosis and higher applicability of the products.
On the other hand, the vital sign monitors are commonly used and expected to grow at the fastest growth over the forecast period. Among these, the heart rate monitor are dominating the product sub-segment owing to the rising incidence of cardiac diseases globally. The surge in the number of individuals with heart disorders has led to the increased usage of these monitors.
On the basis of Application, cardiovascular disease treatment segment is expected to witness lucrative growth over the forecast period
The cardiovascular disease emerged as the leading application segment in 2019, due to the increasing prevalence of the disease. Globally, rising geriatric population and the crisis of chronic diseases are expected to be the high impact rendering drivers for the growth over the forecast period. Cardiovascular disease (CVD) is estimated to cause the annual deaths of 25 million people globally by 2030, and patients can often deteriorate rapidly after the onset of symptoms. A preventative approach to the CVD treatment could see implantable RPMs used in at-risk patients, alerting medical centers to early warning signs of cardiac arrest.
Based on end-users, the global remote patient monitoring market is broadly segmented into providers, payers, patients, and other end users. The providers' segment accounted for the largest share of the global market in 2019. This can be attributed to the increased adoption of remote monitoring in chronically ill and old aged patients, advancements in RPM monitoring devices, and the increasing number of RPM services offered by providers.
In terms of region, the global remote patient monitoring (RPM) market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounted for the largest market share of the global Remote Patient Monitoring (RPM) market in 2019, owing to rising prevalence of chronic conditions, the need to reduce healthcare expenditure, and increasing geriatric population. The U.S. is projected to have diabetes prevalence rise to 29.6% by 2030, and the cost of heart disease treatment triple. These chronic health problems will provide significant demand for RPM devices in the future, and the availability of reimbursement is expected to continue to drive future growth.
Also, increasing technological advancements in remote monitoring owing to the recent outbreak of COVID-19 is leading to the growth of the market in this region. For instance, in August 2020, Validic, a Durham, NC-based provider of health data platforms and solutions for scaling remote patient monitoring (RPM), has launched its remote patient monitoring solution, Validic Impact which offers the ability to deploy an end-to-end technology solution for chronic and acute condition monitoring, rapidly. The Validic Impact solutions can support the management of acute and chronic conditions, such as diabetes, hypertension, heart failure, and COVID-19 (coronavirus). This new version of Validic Impact requires no EHR integration and can be used as a fully standalone solution.
Some of the major players in Remote Patient Monitoring (RPM) market include Koninklijke Philips N.V. , Medtronic, GE Healthcare, Abbott Laboratories, BioTelemetry Inc., Siemens Healthineers AG, Boston Scientific Corporation, OMRON Healthcare, Teladoc Health Inc., Welch Allyn, Vivify Health, Inc., Cerner Corporation, among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the Remote Patient Monitoring (RPM) market globally. For instnace,
Medtronic plc, founded in 1949, is a global medical device company. Its headquarters are in Dublin, Ireland. Medtronic has four operating segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes, and each group is separated into business divisions that deliver a wide range of medical technologies, therapies, services, and solutions. Medtronic operates in more than 140 countries. It employs over 85,000 people and has more than 53,000 patents.
The global remote patient monitoring (RPM) market report would provide an access to an approx. 61 market data table, 56 figures and 250 pages.
LIST NOT EXHAUSTIVE